169 related articles for article (PubMed ID: 33179893)
1. Evidence to Avoid Overtesting and Overuse in Diabetes Mellitus and Other Diseases.
Barry K; Slawson DC; Shaughnessy AF
Am Fam Physician; 2020 Nov; 102(10):583-584. PubMed ID: 33179893
[No Abstract] [Full Text] [Related]
2. The Human Factor: The Cost of Switching from Analog to Human Insulin.
Tsai A
Diabetes Forecast; 2017 Mar; 70(2):44-47. PubMed ID: 29897684
[No Abstract] [Full Text] [Related]
3. Many older people may be overtreated for diabetes, US study finds.
Mayor S
BMJ; 2015 Jan; 350():h188. PubMed ID: 25588872
[No Abstract] [Full Text] [Related]
4. Insulin Access and Affordability Working Group: Conclusions and Recommendations.
Cefalu WT; Dawes DE; Gavlak G; Goldman D; Herman WH; Van Nuys K; Powers AC; Taylor SI; Yatvin AL;
Diabetes Care; 2018 Jun; 41(6):1299-1311. PubMed ID: 29739814
[No Abstract] [Full Text] [Related]
5. The application of evidence-based principles of care in older persons (issue 3): management of diabetes mellitus.
Zarowitz BJ; Tangalos EG; Hollenack K; O'Shea T
J Am Med Dir Assoc; 2006 May; 7(4):234-40. PubMed ID: 16698510
[No Abstract] [Full Text] [Related]
6. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.
Mori K; Emoto M; Abe M; Inaba M
J Diabetes Sci Technol; 2019 Mar; 13(2):413-414. PubMed ID: 30580579
[No Abstract] [Full Text] [Related]
7. A New Algorithm Dedicated to Blood Glucose Monitoring in Insulin-Treated Elderly Dependent People With Diabetes.
Grino M; Loundou A; Boucekine M; Alitta Q; Oliver C
J Diabetes Sci Technol; 2019 Mar; 13(2):410-412. PubMed ID: 30537870
[No Abstract] [Full Text] [Related]
8. [Screening and prevention of diabetes].
Chiasson JL
Perspect Infirm; 2006; 4(2):18-21. PubMed ID: 17184092
[No Abstract] [Full Text] [Related]
9. Biosimilar Insulin and Costs: What Can We Expect?
Heinemann L
J Diabetes Sci Technol; 2015 Sep; 10(2):457-62. PubMed ID: 26350722
[TBL] [Abstract][Full Text] [Related]
10. Standards of medical care in diabetes--2012.
American Diabetes Association
Diabetes Care; 2012 Jan; 35 Suppl 1(Suppl 1):S11-63. PubMed ID: 22187469
[No Abstract] [Full Text] [Related]
11. HONE IN ON THE RANGE.
Scheiner G
Diabetes Self Manag; 2015; 32(4):18-20, 23. PubMed ID: 26380396
[No Abstract] [Full Text] [Related]
12. Diabetes News.
Regier EE; Gao HX; Close KL
J Diabetes; 2015 Nov; 7(6):749-53. PubMed ID: 26223410
[No Abstract] [Full Text] [Related]
13. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
Davidson MB
JAMA; 2017 Jan; 317(4):363-364. PubMed ID: 28118435
[No Abstract] [Full Text] [Related]
14. The right drug at the right dose (how doctors decide what to prescribe).
Marino MT
Diabetes Self Manag; 2011; 28(2):8, 10-2, 14. PubMed ID: 21510246
[No Abstract] [Full Text] [Related]
15. [New, expensive antidiabetics for the treatment of type-2 diabetes--contra].
Nawroth P
Dtsch Med Wochenschr; 2010 May; 135(18):923. PubMed ID: 20425679
[No Abstract] [Full Text] [Related]
16. Treatment-induced neuropathy of diabetes: a call for acknowledgement.
Storz MA
Diabet Med; 2020 Feb; 37(2):369-370. PubMed ID: 31318986
[No Abstract] [Full Text] [Related]
17. Biosimilar vs originator insulins: Systematic review and meta-analysis.
Yamada T; Kamata R; Ishinohachi K; Shojima N; Ananiadou S; Nom H; Yamauchi T; Kadowaki T
Diabetes Obes Metab; 2018 Jul; 20(7):1787-1792. PubMed ID: 29536603
[TBL] [Abstract][Full Text] [Related]
18. Intensified glucose control in type 2 diabetes--whose agenda?
Yudkin JS; Richter B; Gale EA
Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
[No Abstract] [Full Text] [Related]
19. Monitoring blood glucose control: what does the future hold?
Cameron B; Berard L
Can J Diabetes; 2015 Jun; 39(3):190-1. PubMed ID: 25840944
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 infection-related diabetes mellitus.
Beliard K; Wilkes M; Yau M; Aluf A; Rapaport R
J Diabetes; 2021 Jun; 13(6):523-524. PubMed ID: 33660918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
